LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan
· Delayed Price · Currency is TWD 67.30
-3.00 (-4.27%)
Apr 29, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 5.67 billion as of April 29, 2026. Its market cap has increased by 211.06% in one year.
Market Cap
5.67B
Enterprise Value
5.18B
Revenue
243.15M
Ranking
n/a
PE Ratio
23.12
Stock Price
67.30
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 5.67B, an increase of 229.02%. That is a compound annual growth rate of 5.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 5.77B |
| Orient Pharma | 5.81B |
| Formosa Laboratories | 6.16B |
| Easywell Biomedicals | 5.02B |
| Orient EuroPharma | 4.06B |
| Merdury Biopharmaceutical | 3.50B |
| Alar Pharmaceuticals | 10.15B |
| Allied Biotech | 3.08B |